[Springer] Metabolic benefits of ketohexokinase inhibition in individuals with MASLD: a randomized placebo-controlled crossover trial

nkrontir Post time 2026-10-16 15:35:37 | Show all posts |Read mode
This post will be closed automatically in 2026-10-19 15:33
Reward40points

journal: Nature Metabolism

Authors: Evi J. C. Koene, Vera B. Schrauwen-Hinderling, Jeremy Basset-Sagarminaga, Kim Brouwers, Yvonne M. H. Op den Kamp-Bruls, Julian Mevenkamp, Florian Haans, Gert Schaart, Esther Kornips, Johanna A. Jorgensen, Jean L. J. M. Scheijen, Casper G. Schalkwijk, Michel van Weeghel, Fr谷d谷ric M. Vaz, Riekelt H. Houtkooper, Elva Wong, Sander Kersten, Aditi R. Saxena, William P. Esler, Patrick Schrauwen & Martijn C. G. J. Brouwers

Published date: 07 October 2026

DOI: 10.1038/s42255-026-01626-5

PDF link: https://link.springer.com/content/pdf/10.1038/s42255-026-01626-5.pdf

Article link: https://link.springer.com/article/10.1038/s42255-026-01626-5

Article SourceㄩSpringer Science and Business Media LLC﹝


Remark:

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Vikani Post time 2026-10-16 15:35:38 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    19250


Daily Top Contributors

Return to the list